Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
NC1-M52H4 | Mouse | Mouse NCAM-1 / CD56 Protein, His Tag | ![]() |
![]() ![]() |
|
NC1-HF2H5 | Human | FITC-Labeled Human NCAM-1 / CD56 Protein, His Tag | ![]() |
![]() ![]() |
|
NC1-HF256 | Human | FITC-Labeled Human NCAM-1 / CD56 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
NC1-H82E3 | Human | Biotinylated Human NCAM-1 / CD56 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
NC1-H5253 | Human | Human NCAM-1 / CD56 Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
NC1-H5223 | Human | Human NCAM-1 / CD56 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
Immobilized Biotinylated Human NCAM-1, His,Avitag (Cat. No. NC1-H82E3) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-NCAM-1 Antibody, Human IgG1 with a linear range of 1-5 ng/mL (QC tested).
The purity of Biotinylated Human NCAM-1, His,Avitag (Cat. No. NC1-H82E3) is more than 90% and the molecular weight of this protein is around 115-125 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
GD2/CD56 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute) | bi-4SCAR GD2/CD56 | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | Neoplasms | Details |
Lorvotuzumab mertansine | BB-10901; IMGN-901; huN-901-DM1; IMGN-901-TAP; huN-901-SPP-DM1 | Phase 2 Clinical | Immunogen Inc | Rhabdomyosarcoma; Leukemia; Ovarian Neoplasms; Carcinoma, Merkel Cell; Wilms Tumor; Small Cell Lung Carcinoma; Sarcoma, Synovial; Multiple Myeloma; Neurofibrosarcoma; Neuroblastoma; Carcinoma, Small Cell | Details |
This web search service is supported by Google Inc.